Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02978872 · ClinicalTrials.gov registry record
Quantra Determination of Coagulation Parameters in Arterial and Venous Blood
A clinical trial, sponsored by HemoSonics.
- Completed
- Registry status
- 30
- Enrollment target
NCT02978872: Completed study, sponsored by HemoSonics.
NCT02978872 is a clinical trial that has completed, run by HemoSonics. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02978872 has completed, sponsored by HemoSonics.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The Quantra™ System is a novel point-of-care diagnostic device designed to perform whole blood coagulation analysis. This study compares Quantra measurements determined in arterial versus venous blood samples obtained from patients undergoing cardiac surgery.
Primary Outcome
Coagulation function assessed by Quantra at 2 time points (Baseline and either during cardiac bypass or post-bypass)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-07 |
| Est. Completion | 2017-01 |
What the finished NCT02978872 record still lists
NCT02978872 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02978872 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02978872 about?
NCT02978872 is a clinical study titled "Quantra Determination of Coagulation Parameters in Arterial and Venous Blood". The Quantra™ System is a novel point-of-care diagnostic device designed to perform whole blood coagulation analysis. This study compares Quantra measurements determined in arterial versus venous blood samples obtained from patients undergoing cardiac surgery.
What is the current status of trial NCT02978872?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2016-07. Estimated completion is 2017-01.
Who is sponsoring clinical trial NCT02978872?
This trial is sponsored by HemoSonics, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia